Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pham

Showing results (291-300 of 322) with videos related to

Pageof 33
Sort By:
Nature Communications|May 28, 2026
Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of estrogen receptor-positive breast cancer brain metastasesMorgan S Fox, Jenny A Jaramillo-Gómez, R Alejandro Marquez-Ortiz, et al.
Cancer Discovery|November 19, 2020
Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK PathwaysTrang H Pham, Thijs J Hagenbeek, Ho-June Lee, et al.
Plos Biology|September 17, 2019
MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibitionLieselotte Vande Walle, Irma B Stowe, Pavel Šácha, et al.
Plos Biology|October 17, 2019
Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibitionLieselotte Vande Walle, Irma B Stowe, Pavel Šácha, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2025
Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathologyAlexandra C Bayer, Liliana M Sanmarco, Alex Pellerin, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2018
A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppressionKathleen M Mahoney, Sachet A Shukla, Nikolaos Patsoukis, et al.
Hypertension (Dallas, Tex. : 1979)|November 14, 2024
Left Ventricular Hypertrophy in Women With a History of PreeclampsiaMaria G Hauge, Peter Damm, Klaus F Kofoed, et al.
Cancer Research Communications|September 26, 2024
ATF6 Promotes Colorectal Cancer Growth and Stemness by Regulating the Wnt PathwayJeffrey J Rodvold, Matthew Grimmer, Karen Ruiz, et al.
The New England Journal of Medicine|May 25, 2017
Cardiovascular and Metabolic Effects of ANGPTL3 Antisense OligonucleotidesMark J Graham, Richard G Lee, Teresa A Brandt, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2020
Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophyIrene Tom, Victoria C Pham, Kenneth J Katschke, et al.
Pageof 33

Showing results (291-300 of 322) with videos related to

Sort By:
Pageof 33
Nature Communications|May 28, 2026
Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of estrogen receptor-positive breast cancer brain metastasesMorgan S Fox, Jenny A Jaramillo-Gómez, R Alejandro Marquez-Ortiz, et al.
Cancer Discovery|November 19, 2020
Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK PathwaysTrang H Pham, Thijs J Hagenbeek, Ho-June Lee, et al.
Plos Biology|September 17, 2019
MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibitionLieselotte Vande Walle, Irma B Stowe, Pavel Šácha, et al.
Plos Biology|October 17, 2019
Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibitionLieselotte Vande Walle, Irma B Stowe, Pavel Šácha, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2025
Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathologyAlexandra C Bayer, Liliana M Sanmarco, Alex Pellerin, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2018
A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppressionKathleen M Mahoney, Sachet A Shukla, Nikolaos Patsoukis, et al.
Hypertension (Dallas, Tex. : 1979)|November 14, 2024
Left Ventricular Hypertrophy in Women With a History of PreeclampsiaMaria G Hauge, Peter Damm, Klaus F Kofoed, et al.
Cancer Research Communications|September 26, 2024
ATF6 Promotes Colorectal Cancer Growth and Stemness by Regulating the Wnt PathwayJeffrey J Rodvold, Matthew Grimmer, Karen Ruiz, et al.
The New England Journal of Medicine|May 25, 2017
Cardiovascular and Metabolic Effects of ANGPTL3 Antisense OligonucleotidesMark J Graham, Richard G Lee, Teresa A Brandt, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2020
Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophyIrene Tom, Victoria C Pham, Kenneth J Katschke, et al.
Pageof 33